Transcept Pharmaceuticals

edit

Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company’s first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.

Milestones

edit

• 
  Transcept Pharmaceuticals received $40M in Series D funding. (3/8/07)
  Posted 9/16/09 at 6:17am

Videos

Screenshots

edit

Sources

1. Insomnia drug company, TransOral, raises $40M more (deals.venturebeat.com) [edit]